← back to search

Yanmei Liu

The First Affiliated Hospital, Sun Yat-sen University · CN
Area of research
Surgery · Endocrinology, Diabetes and Metabolism
Research interest
Research focused on Meta-analysis and microRNA, with related work in Glucagon receptor, p38 mitogen-activated protein kinases, PI3K/AKT/mTOR pathway. Notable publications include 'Artificial Liver Support System Improves Short- and Long-Term Outcomes of Patients With HBV-Associated Acute-on-Chronic Liver Failure', 'Diagnostic value of serum IGF-1 and IGFBP-3 in growth hormone deficiency: a systematic review with meta-analysis', and 'microRNA-503 contribute to pancreatic β cell dysfunction by targeting the mTOR pathway in gestational diabetes mellitus'.
h-index
citations
391
works
13
NIH funding
primary concept
email

Recent publications

Ergothioneine Treatment Ameliorates the Pathological Phenotypes of Parkinson's Disease Models
Journal of Neurochemistry 2025cited by 7position: middledoi
Shenlingcao oral liquid for patients with non-small cell lung cancer receiving adjuvant chemotherapy after radical resection: A multicenter randomized controlled trial
Phytomedicine 2023cited by 16position: firstdoi
The discovery of a new type of innervation in lymphoid organs
Physiological Reports 2023cited by 6position: middledoi
BBRv2+: Towards balancing aggressiveness and fairness with delay-based bandwidth probing
Computer Networks 2022cited by 23position: middledoi
Glucagon Potentiates Insulin Secretion Via β-Cell GCGR at Physiological Concentrations of Glucose
Cells 2021cited by 40position: lastdoi
Outcomes of icotinib combined with concurrent chemoradiotherapy in locally advanced cervical cancer
Neoplasma 2021cited by 3position: firstdoi
Comparison of the combination of recombinant follicle‐stimulating hormone and recombinant luteinizing hormone protocol versus human menopausal gonadotropin protocol in controlled ovarian stimulation: A systematic review and meta‐analysis
Journal of Evidence-Based Medicine 2020cited by 10position: middledoi
High NUSAP1 expression predicts poor prognosis in colon cancer
Pathology - Research and Practice 2018cited by 41position: middledoi
microRNA-503 contribute to pancreatic β cell dysfunction by targeting the mTOR pathway in gestational diabetes mellitus
PubMed 2017cited by 44position: lastdoi
Particulate Matter Facilitates C6 Glioma Cells Activation and the Release of Inflammatory Factors Through MAPK and JAK2/STAT3 Pathways
Neurochemical Research 2016cited by 19position: middledoi
Identifying patients with chronic hepatitis B at high risk of type 2 diabetes mellitus: a cross-sectional study with pair-matched controls
BMC Gastroenterology 2015cited by 26position: middledoi
Artificial Liver Support System Improves Short- and Long-Term Outcomes of Patients With HBV-Associated Acute-on-Chronic Liver Failure
Medicine 2014cited by 91position: middledoi
Diagnostic value of serum IGF-1 and IGFBP-3 in growth hormone deficiency: a systematic review with meta-analysis
European Journal of Pediatrics 2014cited by 65position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yi Shen · Nantong University3 papers (2014–2015)Jianguo Shao · Nantong University2 papers (2014–2015)Youyi Zhang · Fudan University2 papers (2014–2015)Gang Qin · Central South University2 papers (2014–2015)Jiali Liu · Shandong University2 papers (2020–2023)Jianbin Yang · Nantong University1 papers (2016–2016)Jian Zheng · Nantong University1 papers (2014–2014)Cheng Wang · Hubei Engineering University1 papers (2016–2016)Lujun Wang · Chinese PLA General Hospital1 papers (2014–2014)Yan Ding · Children’s Institute1 papers (2021–2021)Yulin Zhang · Shanghai Medical College of Fudan University1 papers (2021–2021)Jie Qin · Shandong University of Technology1 papers (2017–2017)Yuning Wang · Suzhou Academy of Agricultural Sciences1 papers (2020–2020)Yuanyuan Xu · Fudan University1 papers (2021–2021)Fei Huang · Nantong University1 papers (2017–2017)Changlai Zhu · Nantong University1 papers (2023–2023) · 1 papers (2023–2023)Xianjin Liu · Jiangsu University1 papers (2014–2014)Lanxiang Hao · Nantong University1 papers (2017–2017)Haitao Ma · Guilin Medical University1 papers (2023–2023)